Kirti Y K, Soni Smita, Yashveer J K, Anjali A R
Department of Otolaryngology, Gandhi Medical College, Bhopal, India.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3416-3419. doi: 10.1007/s12070-021-02632-7. Epub 2021 May 17.
To evaluate the problems in doing emergency tracheostomy and tracheostomy care of patients with unknown COVID-19 status. Study the usefulness of the specially designed Tracheostomy Shield. A prospective hospital-based study was conducted at a tertiary care center in India treating COVID and Non COVID patients. The study was done from April 2020 to December 2020. A total of 80 tracheostomy were done using Tracheostomy shield. Open tracheostomies were 38 while 42 patients were already intubated (closed circuit). The Tracheostomy shield was also used in 380 tracheostomy tubes changes. Two patients were found COVID positive on RT-PCR after tracheostomy. There was no scope for testing all tube changes with RT-PCR. The use of our indigenously designed Tracheostomy shield has been effective in reducing the aerosol spread and there was no COVID transmission reported. The use of patient Tracheostomy shield is of uttermost importance in reducing the respiratory droplets splashing on to the surgeon and assistant while doing awake tracheostomy. It is extremely useful while changing tubes as there are chances of false negatives antigen test which might be miss leading. The use of Tracheostomy shield is very important in the current context of new and fast evolving respiratory infections.
评估对新冠病毒感染状况不明的患者进行紧急气管切开术及气管切开护理时存在的问题。研究特制气管切开防护罩的实用性。在印度一家治疗新冠患者和非新冠患者的三级医疗中心开展了一项基于医院的前瞻性研究。该研究于2020年4月至2020年12月进行。共使用气管切开防护罩进行了80例气管切开术。其中开放性气管切开术38例，42例患者已进行插管（闭合回路）。气管切开防护罩还用于380次气管切开套管更换。气管切开术后，有2例患者经逆转录聚合酶链反应检测新冠呈阳性。无法对所有套管更换进行逆转录聚合酶链反应检测。我们自主设计的气管切开防护罩在减少气溶胶传播方面很有效，且未报告有新冠病毒传播情况。在进行清醒气管切开术时，使用患者气管切开防护罩对于减少呼吸道飞沫溅到外科医生和助手身上至关重要。在更换套管时它极其有用，因为存在抗原检测假阴性的可能性，这可能会产生误导。在新型快速演变的呼吸道感染的当前背景下，使用气管切开防护罩非常重要。
